Warning letter
Jubilant HollisterStier, LLC: warning letter of Nov 27, 2013
FDA warning letter 406275 · Seattle District Office
Key facts
| Reference number | 406275 |
|---|---|
| Company | Jubilant HollisterStier, LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Nov 27, 2013 |
| Posted date | Nov 27, 2013 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| CFR sections cited | 211.42(c)(10)(v), 211.113(b) |
| Inspection city | Spokane |
| Inspection ZIP | 99207 |
| Inspection start date | Apr 15, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: